With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
November 2016: This action was voluntarily dismissed pursuant to a settlement agreement reached between the parties, the terms of which have not been disclosed.
September 2016: The parties in a class-action lawsuit filed against Patent Health, L.L.C. in 2013 for allegedly deceptively marketing Trigosamine glucosamine supplements, reached a settlement agreement. The plaintiffs had alleged that the company deceptively claimed the supplements provide a variety of health benefits – including relieving joint pain, lubricating joints, and building cartilage – without adequate scientific evidence to support such claims. The terms of the settlement agreement have not been disclosed. (Vasic et al v. Patent Health, L.L.C. et al, Case No. 13-cv-849, S. D. CA.)
For more information about other class-action lawsuits regarding glucosamine supplements and TINA.org’s coverage of the products, click here.
TINA.org and other consumer advocates file comment with FTC.
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Marketing and reality are not in sync.
New study opens the floodgates to class-action litigation.
Agency alleges MLM misled recruits about earnings, pressured distributors to buy products and encouraged fake retail sales.